RAN pseudogene 3 (RANP3)

RAN pseudogene 3 (RANP3) is classified as a processed pseudogene typically derived from the RAN gene, a small GTPase involved in nucleocytoplasmic transport, cell cycle regulation, and chromatin organization[5]. Pseudogenes like RANP3 do not code for proteins due to mutations such as frameshifts or premature stop codons, and are generally considered transcriptionally and functionally inactive[1][3][4]. While some pseudogenes can occasionally regulate their parent gene or act as regulatory RNAs, there is no evidence that RANP3 has such functions. RANP3 is not considered a therapeutic target, receptor, enzyme, transporter, or clinically actionable entity[1][3][4]. Key Notes: - There is nothing to suggest that RANP3 is an actionable or canonical drug discovery target. - “RAN pseudogene 3” reflects a non-coding, likely non-functional genetic element; it is not a receptor, enzyme, or functional protein. - Entries like this are often included in gene databases but should not be confused with functional molecular targets. - If you intended to refer to RAN (ras-related nuclear protein) itself, which is a functional small GTPase, that would be a different entity[5]. Correction: “RAN pseudogene 3” should not be used as a therapeutic or molecular target designation. For functional targeting, refer to the protein-coding RAN gene.

Other names

ras-related nuclear protein pseudogene 3